Search
BNB Plus Ord Shs
BNBXAdd to Watchlist
0.163USD
0.0000.00%
Close 07-13 16:00（ET）
836.63KMarket Cap
0.00P/E TTM
BNB Plus Ord Shs (BNBX) Revenue Performance
Updated: Dec 31, 2025By Business
Revenue
Proportion
Annual
Annual
Quarterly
Product and authentication services - Supply chain
Product and authentication services - Large scale DNA production
Research and development services
Product and authentication services - Asset marking
Clinical laboratory testing services (over-time)
Clinical laboratory testing services (point-in-time)
Product and authentication services - Diagnostic kits
Clinical laboratory testing services
FY2025
FY2024
FY2023
FY2022
FY2021
Product and authentication services - Supply chain
1.15M(53.76%)
1.21M(35.22%)
827.60K(6.19%)
887.06K(4.88%)
1.00M(11.11%)
Product and authentication services - Large scale DNA production
612.36K(28.66%)
584.12K(17.02%)
653.01K(4.89%)
--(--)
--(--)
Research and development services
375.76K(17.58%)
311.24K(9.07%)
421.58K(3.15%)
592.00K(3.26%)
799.72K(8.86%)
Product and authentication services - Asset marking
--(--)
9.44K(0.28%)
311.81K(2.33%)
534.59K(2.94%)
458.41K(5.08%)
Clinical laboratory testing services (over-time)
--(--)
1.29M(37.46%)
3.54M(26.49%)
5.13M(28.22%)
--(--)
Clinical laboratory testing services (point-in-time)
--(--)
32.61K(0.95%)
7.61M(56.95%)
10.40M(57.23%)
--(--)
Product and authentication services - Diagnostic kits
--(--)
--(--)
--(--)
628.29K(3.46%)
1.97M(21.85%)
Clinical laboratory testing services
--(--)
--(--)
--(--)
--(--)
4.79M(53.10%)
By Region
Revenue
Proportion
Annual
Annual
Quarterly
Asia and other
United States (Country)
Europe
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Asia and other
1.02M(47.76%)
989.23K(28.83%)
886.44K(6.63%)
175.39K(0.97%)
147.89K(1.64%)
499.48K(25.86%)
622.40K(11.55%)
United States (Country)
1.01M(47.30%)
2.27M(66.15%)
12.22M(91.44%)
17.54M(96.56%)
8.52M(94.38%)
1.17M(60.33%)
4.17M(77.31%)
Europe
105.58K(4.94%)
172.37K(5.02%)
258.36K(1.93%)
448.85K(2.47%)
359.51K(3.98%)
266.70K(13.81%)
600.37K(11.14%)